Germany's benefit assessment for medicines already on the market - an uncertain outlook
This article was originally published in SRA
Jörg Schickert and Martin Pawlak examine some of the turbulent developments in drug pricing and reimbursement in Germany.
You may also be interested in...
Results of a pivotal trial show BrainCool’s Cooral system is significantly more effective than the standard of care therapy in preventing oral mucositis in lymphoma patients.
Centaur-CytoTools introduces novel topical treatment for diabetic foot ulcers in India, for which they see limited direct competition and hope to change the way the difficult-to-treat diabetes complication is managed. Phase III studies are ongoing in Europe.
The head of the US Food and Drug Administration praised the life-saving work of device center staff in response to the coronavirus pandemic.